A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.
A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.
复制标题
DOI:
10.1038/onc.2015.68
复制
发表时间:
2016-01-07
期刊:
影响因子:
8
通讯作者:
Kupfer GM
中科院分区:
文献类型:
--
作者:
Chen X;Bosques L;Sung P;Kupfer GM
Fanconi anemia (FA) is a genetic disease of bone marrow failure, cancer susceptibility, and sensitivity to DNA crosslinking agents. FANCD2, the central protein of the FA pathway, is monoubiquitinated upon DNA damage, such as crosslinkers and replication blockers such as hydroxyurea (HU). Even though FA cells demonstrate unequivocal sensitivity to crosslinkers, such as mitomycin C (MMC), we find that they are largely resistant to hydroxyurea (HU), except for cells absent for expression of FANCD2. FANCD2, RAD51, and RAD18 form a complex, which is enhanced upon HU exposure. Surprisingly, while FANCD2 is required for this enhanced interaction, its monoubiquitination is not. Similarly, non-ubiquitinated FANCD2 can still support PCNA monoubiquitination. RAD51, but not BRCA2, is also required for PCNA monoubiquitination in response to HU, suggesting that this function is independent of homologous recombination (HR). We further show that TLS polymerase PolH chromatin localization is decreased in FANCD2 deficient cells, FANCD2 siRNA knock down cells, and RAD51 siRNA knock down cells, and PolH knockdown results in HU sensitivity only. Our data suggest that FANCD2 and RAD51 play an important role in PCNA monoubiquitination and TLS in a FANCD2 monoubiquitination and HR-independent manner in response to HU. This effect is not observed with MMC treatment, suggesting a non-canonical function for the FA pathway in response to different types of DNA damage.